Horlen C K, Seifert C F, Malouf C S
School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock 79430, USA.
Ann Pharmacother. 2000 Nov;34(11):1273-5. doi: 10.1345/aph.10028.
To report a case of changes documented by magnetic resonance imaging (MRI) of the head probably due to accumulation of metronidazole in a patient with liver dysfunction.
A 34-year-old Hispanic man with cirrhosis and hepatitis C being treated with metronidazole for Bacteroides fragilis meningitis and bacteremia developed ataxia, disorientation, and peripheral neuropathy. An MRI at the time meningitis was diagnosed was negative. After the patient received > 60 g of metronidazole, an MRI revealed increased signal intensity below, behind, and lateral to the fourth ventricle. Concomitant metronidazole serum concentration was toxic at 35.1 micrograms/mL.
This is the second reported case of metronidazole-induced MRI changes. Metronidazole is known to accumulate in patients with liver dysfunction and can cause peripheral neuropathy and central nervous system (CNS) dysfunction; these effects may take up to two years to completely resolve.
Metronidazole dosages should be reduced in patients with liver dysfunction to prevent the accumulation of metronidazole, which can lead to CNS dysfunction and peripheral neuropathy.
报告一例肝功能不全患者头部磁共振成像(MRI)记录的变化,可能是由于甲硝唑蓄积所致。
一名34岁的西班牙裔男性,患有肝硬化和丙型肝炎,因脆弱拟杆菌性脑膜炎和菌血症接受甲硝唑治疗,出现共济失调、定向障碍和周围神经病变。脑膜炎诊断时的MRI检查结果为阴性。患者接受超过60克甲硝唑后,MRI显示第四脑室下方、后方和外侧信号强度增加。同时,甲硝唑血清浓度为35.1微克/毫升,呈毒性水平。
这是第二例报告的甲硝唑引起MRI变化的病例。已知甲硝唑会在肝功能不全患者体内蓄积,并可导致周围神经病变和中枢神经系统(CNS)功能障碍;这些影响可能需要长达两年才能完全消退。
肝功能不全患者应减少甲硝唑剂量,以防止甲硝唑蓄积,其可导致中枢神经系统功能障碍和周围神经病变。